Lapsi Health
Lapsi Health is a Dutch medical technology company that develops the FDA-cleared Keikku 2.0 digital stethoscope and AI-powered clinical platform (Scribe, Reference) for healthcare providers, automating auscultation, documentation, and diagnostic support.
- Company typePrivate
- Founded2022
- HeadquartersAmsterdam, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
Lapsi Health firmographics
Firmographics- Name
- Lapsi Health
- Website
- https://lapsihealth.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Lapsi Health is a Dutch medical technology company that develops the FDA-cleared Keikku 2.0 digital stethoscope and AI-powered clinical platform (Scribe, Reference) for healthcare providers, automating auscultation, documentation, and diagnostic support.
- Ownership category
- akta.pro rank
Lapsi Health industry classification
Industry- Product category
- Digital Health Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Computer Systems Design and Related Services (54151)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD), SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE)
Keywords
Where Lapsi Health is headquartered
LocationHeadquarters
- HQ city
- Amsterdam
- HQ country
- Netherlands
- HQ region
- Europe
Offices2 records
Markets served
Lapsi Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Hardware Sales (Keikku Device): Sale of FDA-cleared Keikku 2.0 digital stethoscope hardware to healthcare providers and institutions. The device serves as the hardware foundation for the AI-powered clinical platform.
- Software Subscriptions (Scribe & Reference): Subscription-based access to AI-powered clinical documentation (Scribe) and clinical reference (Reference) modules. The platform offers a freemium entry point with premium enterprise tiers.
- Enterprise Platform Licensing: Enterprise tier offerings providing comprehensive access to the clinical AI platform for larger healthcare organizations, including dedicated support and advanced features.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free tier - Get Keikku free |
| Subscription | Annual | Enterprise tier - Get Keikku free (Enterprise) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Lapsi Health product offering
Product offeringCore offering
Lapsi Health develops the Keikku clinical AI platform, an FDA-cleared ecosystem that pairs a digital stethoscope device with AI-powered software modules—Keikku Scribe for voice-activated clinical documentation and Keikku Reference for cited clinical question answering—plus integrated eMurmur cardiac AI for diagnostic support. The platform converts physician–patient conversations into structured notes, retrieves evidence-based clinical answers, and captures body sounds for auscultation and digital biomarker analysis during consultations.
Product overview
Lapsi Health offers Keikku, a unified FDA-cleared clinical AI platform designed for medical consultations. The platform comprises hardware (the Keikku digital stethoscope device) and software modules (Scribe and Reference) that work independently or together as an integrated ecosystem. Keikku 2.0 represents the flagship product combining FDA-cleared stethoscope hardware with built-in AI Scribe capabilities for real-time auscultation, clinical documentation, and diagnostic support. The platform is designed to improve clinical efficiency and patient care by automating documentation and providing cited clinical references.
Differentiator
Problem solved
Functional benefit
Brands
- Keikku: FDA-cleared digital stethoscope with integrated AI capabilities, including Scribe (AI documentation), Reference (clinical question answering), and hardware components. Keikku 2.0 is the latest version launched in October 2025.
Products and services
- Keikku 2.0 Digital Stethoscope FDA 510(k)-cleared voice-activated digital stethoscope hardware that captures body sounds for real-time auscultation, integrates AI-powered documentation, and supports diagnostic workflows for clinicians and healthcare institutions.
- Keikku Scribe AI-powered clinical documentation module that converts physician–patient conversations into structured medical notes automatically, reducing typing and administrative burden for clinicians.
- Keikku Reference Clinical decision support module that answers clinical questions with cited answers in seconds from trusted medical sources, supporting evidence-based decision-making during consultations.
Quantifiable outcome
- FDA 510(k) clearance achieved for Keikku 2.0 digital stethoscope
- +1 more outcomes
Companies that use Lapsi Health
Customer profileSegments1 record
Ideal customer profiles2 records
Lapsi Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability7 records
Feature5 records
Lapsi Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- eMurmurcoreLapsi Health and eMurmur announced a strategic partnership to integrate eMurmur's AI algorithms into Lapsi Health's Keikku 2.0 FDA-cleared digital stethoscope. The integration combines eMurmur's cardiac AI algorithms with Keikku 2.0's hardware to enhance cardiac auscultation and documentation. This integration is expected to improve clinical diagnostics and efficiency across various healthcare settings, providing enhanced cardiac diagnostic accuracy through AI-powered analysis.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Lapsi Health competitors and assessment
Company assessmentDirect peers
- Suki AI: Suki offers an AI voice assistant for clinicians that generates notes and answers clinical questions, closely overlapping with both Keikku Scribe and Reference. Suki is venture-backed and deployed across US health systems, making it a direct comparable in functionality and target buyer.
- Eko Health: Eko Health is the most direct competitor to Lapsi — both make digital stethoscopes enhanced with FDA-cleared AI algorithms (notably cardiac AI for murmur and AFib detection). Eko has a larger installed base in US health systems and pulmonology/cardiology workflows, making it the closest comparable in product, customer, and regulatory positioning.
- Abridge: Abridge is a leading AI medical scribe that converts clinician-patient conversations into structured notes, directly overlapping with Keikku Scribe. Abridge is well-funded, widely deployed in US health systems, and competes for the same clinical documentation budget that Lapsi targets — albeit without hardware.
Broad incumbents
- Augmedix: Augmedix provides AI-assisted and human-in-the-loop clinical documentation services to US health systems. While not a hardware player, it competes for the same documentation budget and EHR-integrated scribe workflows that Keikku Scribe targets, making it a broader incumbent in adjacent clinical documentation.
- Nuance (Microsoft DAX Copilot): Microsoft's Nuance DAX Copilot is an ambient AI scribe deeply integrated with Epic and other EHRs, and is one of the largest deployed clinical documentation AI products. It competes head-on with Keikku Scribe and Reference inside health systems, and benefits from Microsoft/Azure distribution and capital scale that Lapsi cannot match.
- 3M Littmann (Solventum): 3M Littmann (now Solventum) is the dominant traditional stethoscope brand with deep penetration across clinicians globally. While it does not currently bundle AI scribes, its installed base, brand trust, and clinical relationships represent the incumbent landscape Lapsi must displace — and a likely acquisition/partnership candidate for the Keikku hardware story.
Emerging players
- Nabla: Nabla offers an ambient AI medical scribe that produces clinical notes from patient encounters, directly overlapping with Keikku Scribe. It is venture-backed with US/EU deployment, making it an emerging competitor in the same clinical AI documentation category Lapsi is pursuing.
- Thinklabs One: Thinklabs makes a digital stethoscope focused on high-fidelity sound capture for auscultation and telehealth. It overlaps with Lapsi on the digital stethoscope hardware layer but lacks an integrated AI scribe offering, making it a partial / emerging competitor in the same niche.
- Sonavi Labs: Sonavi Labs develops AI-enabled digital stethoscopes with respiratory/pulmonary diagnostic algorithms (e.g., pneumonia detection). It is comparable to Lapsi on the hardware-plus-AI-auscultation axis and competes for similar clinical use cases in primary care and global health.
- Steth IO (Eko alternative): Steth IO produces a smartphone-based digital stethoscope with AI auscultation capabilities, competing in the same low-cost, software-driven digital stethoscope niche as Keikku Hardware. It is a relevant emerging player, particularly for price-sensitive and telehealth use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lapsi Health social profiles
Digital presenceLapsi Health compliance and trust
Trust signalCompliance2 records
Lapsi Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lapsi Health leadership team
Management profileNumber of profiles
Profiles7 records
Lapsi Health funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lapsi Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lapsi Health
What does Lapsi Health do?
Lapsi Health develops the Keikku clinical AI platform, an FDA-cleared ecosystem that pairs a digital stethoscope device with AI-powered software modules—Keikku Scribe for voice-activated clinical documentation and Keikku Reference for cited clinical question answering—plus integrated eMurmur cardiac AI for diagnostic support. The platform converts physician–patient conversations into structured notes, retrieves evidence-based clinical answers, and captures body sounds for auscultation and digital biomarker analysis during consultations.
Is Lapsi Health a public or private company?
Lapsi Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Lapsi Health founded?
Lapsi Health was founded in 2022. It employs 1 to 10 people.
Where is Lapsi Health based?
Lapsi Health is headquartered in Amsterdam, Netherlands, in the Europe region.
How does Lapsi Health make money?
Three revenue lines are on record. Hardware Sales (Keikku Device) is the primary driver. The others are software Subscriptions (Scribe & Reference) and enterprise Platform Licensing.
Who are Lapsi Health's main competitors?
Direct peers on record are Suki AI, Eko Health and Abridge. Broad incumbents are Augmedix, Nuance (Microsoft DAX Copilot) and 3M Littmann (Solventum). Emerging players are Nabla, Thinklabs One, Sonavi Labs and Steth IO (Eko alternative).
Does Lapsi Health have an API?
No public API is recorded for Lapsi Health.
What industry is Lapsi Health in?
Lapsi Health's product category is Digital Health Medical Devices. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLALABAD, Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology). Its NAICS code is 334510 and its SIC code is 3841.